Biomedical scientists use chemistry-driven processes found in nature as an inspiration to
design biomaterials as promising diagnostic tools, therapeutic solutions, or tissue …

With 18 monoclonal antibody (mAb) products currently on the market and more than 100 in
clinical trials, it is clear that engineered antibodies have come of age as biopharmaceuticals …

Vaccination, especially with multiple doses, provides substantial population-level protection
against COVID-19, but emerging variants of concern (VOC) and waning immunity represent …

The focus of this article is to review the recent advances in proteome analysis of human
body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar …

Of the diverse analytical tools used in proteomics, protein microarrays possess the greatest
potential for providing fundamental information on protein, ligand, analyte, receptor, and …

Microarrays of proteins and peptides make it possible the screening of thousands of binding
events in a parallel and high throughput fashion; therefore they are emerging as a powerful …

The study of protein-protein interactions by mass spectrometry is an increasingly important
part of post-genomics strategies to understand protein function. A variety of mass …

Extracellular vesicles (EV) are membranous particles (30–1,000 nm in diameter) secreted by
cells. Important biological functions have been attributed to 2 subsets of EV, the exosomes …

Protein microarray technology has enormous potential for in vitro diagnostics (IVD).
Miniaturized parallelized immunoassays are perfectly suited to generating a maximum of …

Antibody arrays are valuable for the parallel analysis of multiple proteins in small sample
volumes. The earliest and most widely used application of antibody arrays has been to …